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Twenty-five patients with T3-thyrotoxicosis were studied. The diagnosis was based 
on clinical observation, biochemical values, total T3 and T4, and ultrasound tests of the 
thyroid gland. A conservative treatment was carried out and where necessary a surgical 
one, too. The authors observed this form of the thyrotoxicosis in male as well as in 
female patients, the average age of the patients was young, and the duration of the 
disease from its beginning until diagnosing was longer than that of the common form.A 
bigger size of the thyroid was observed which was denser and often pseudonodular. In 
the clinical picture the cardio-vascular and neurological symptoms prevailed. Only in 
two cases light forms of thyrotoxic ophthalmopatia developed. The disease showed 
tendency towards relapses. Four patients were operated on because of difficulties in 
achieving a compensation of the euthyroid state and frequent relapses. 
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Among all endocrine diseases 
the thyroid pathology takes the second 
place in incidence rate after diabetes 
mellitus. Thyrotoxicosis is well 
known disease which is not a serious 
diagnostic and therapeutic problem. 
However, our experience shows that 
even patients with typical 
development of the disease are treated 
for a long time for another diagnosis. 
The reason is the late identification of 
atypical forms of thyrotoxicosis. Such 
an atypical form is the T3-
thyrotoxicosis. 
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In a lot of researches, including 
patients with goiter in endemic 
regions, a low levels of T 4 and levels 
of T3 near to the upper limit were 
found (1,2,4). The question about the 
decisive role of T3 and T 4 for 
thyrotoxicosis is still eagerly 
discussed (6). 
In 1972, Hollender and al. (5) 
described for the first time an atypical 
form of thyrotoxicosis with elevated 
serum triiodthyronin (T3) but normal 
serum thyroxine (T4) concentrations. 
M A T E R I A L AND METHODS 
In order to describe more 
precisely the clinical features and 
hormonal state, 25 patients (24 with 
Grave's disease and one patient with 
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thyroid adenoma), treated in the clinic 
of endocrinology, Medical University, 
Varna for the period 1988/1989, were 
studied (6,68 percent of all cases of 
thyrotoxicosis). A parallel group of 25 
patients with typical form of Grave's 
disease was studied. 
We used the following 
laboratory methods: serum thyroid 
hormone measurements, ultrasound 
and scanning of thyroid gland, 
biochemical measurements, antithyro-
globulin and antimicrosomal autoanti­
bodies, and TRH-test. 
RESULTS AND DISCUSSION 
The distribution of patients 
according to sex and age showed that 
Тз-thyrotoxicosis was more common 
among women, but not so markedly 
as for the typical forms of 
thyrotoxicosis (in 36% of the cases 
for men against 16% in typical 
forms). The female/male ratio in Тз-
thyrotoxicosis was 1,8:1 and in 
typical forms - 5,25:1. The patients 
with а Тз form were younger. The 
mean age was respectively 39,1 and 
51,87 years. I f we took into 
consideration the late clinical 
identification of the T 3 form the mean 
age of Тз thyrotoxicosis was 25,63 
months, while for the typical forms it 
was 11,38 months. Out of a total of 
25 patients with T 3 thyrotoxicosis 8 
were treated with (3-adrenergic 
antagonist for unknown etiology, four 
patients for neuroses. Arterial 
hypertension was suspected in two 
patients. 
The average duration of the T3 
form was of 64,2 months in contrast 
to the typical forms (17,62 months). 
Perhaps it was a result of the late 
identification and frequent relapses of 
the T3 form. 
Four patients had one relapse, 
five had two relapses, two had three 
relapses. Forteen out of 25 patients 
with T 3 thyrotoxicosis had relapses. 
Four of the patients with a typical 
form had one and one had two 
relapses (p<0,001). 
A characteristic feature of the 
T 3 form was the existence of another 
endocrine disease such as mastopathy 
in two patients, myoma in four, and 
gynaecomastia in one man. Among 
the clinical features of the disease we 
found differences which gave us 
reason to suspect the diagnosis before 
the hormonal measurements. Tachy­
cardia was the leading symptom in T 3 
thyrotoxicosis. It was the only clinical 
feature in five of the patients. 
Neurovegitative symptoms and 
weight loss were the leading mani­
festation of the typical form. 
In the T 3 form, the tachycardia 
(100-120/min), paroxysmal or con­
stant, appeared to be the first reason 
for searching for a medical help. 
There was no case of arrhythmia. The 
cases with arrhythmia in the typical 
form were four out of twenty-five. 
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The explanation could be in the young 
age of the T 3 thyrotoxicosis patients. 
The blood pressure showed the 
typical systolic hypertension in four 
patients with T3 thyrotoxicosis while 
in the typical form it was proved in 
ten cases. Nevertheless, neuropsycho­
logical symptoms were so typical for 
thyrotoxicosis, the emotional lability 
and anxiety often directed the clinical 
thinking to neurosis. The patients 
with thyrotoxicosis were explosive, 
agitated, tearful, they suffered from 
loss of memory, sleeplessness, they 
woke-up easily. 
There were ten patients with 
moderate weight loss, three of them 
had increased appetite. The skin of 
the patients with T3 thyrotoxicosis 
was sweaty, moist, but not always hot. 
It was cold and moist in three women. 
The ocular symptoms were rare in T 3 
thyrotoxicosis. One patient had 
exophthalmus, two - infiltrative 
ophthalmopathy, they were easily 
influenced by the therapy. 
The thyroid enlargement had 
some particular characteristic 
features. In 8 patients the goiter was 
found several years before the first 
clinical signs of hyperthyroidism. 
Usually, the goiter was large, lobed; 
nodules could be suspected in 20 out 
of 25 patients and an ultrasound was 
performed. It revealed the diffuse 
character of the goiter with one 
exception in a patient with thyroid 
adenoma. In 16 patients the goiter 
was homogenous and hypoecho-
genous. The radioiodine scanning 
performed in 19 patients confirmed 
the diffuse nature of the goiter. An 
increased uptake of radioactive 
nuclide was demonstrated. The 
laboratory findings showed high T3 
and normal T 4 levels. In case of 
relapse the proportion of hormones 
was the same. Some authors suppose 
that this is typical of the relapses (3). 
We observed a normal T3/T4 ratio 
during the relapses in the typical 
form. We measured the level of 
cholesterol in all patients. It was 
lower than 4 mmol/1 in 18 out of 25 
patients and 4-4,5 mmol/1 in the 
others. One patient had decreased 
glucose tolerance, while in the typical 
form five patients were with diabetes 
mellitus. T A T and M A T measured in 
17 patients were negative. In five 
patients with T 3 thyrotoxicosis and a 
clinical course typical of Grave's 
disease T R H test was performed. It 
showed a lack of reactivity. 
Along with a patient with 
thyroid adenoma, where surgery was 
indicated, in five patients with diffuse 
goiter an operative intervention was 
performed because we failed to 
achieve a constant euthyroid state. 
Our experience showed that in T 3 
thyrotoxicosis with diffuse goiter the 
surgery was more proper after 
reaching the euthyroid state than long 
lasting conservative treatment in order 
to prevent relapses. There where not 
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hypothyroid symptoms and relapses 
after surgery at all. 
CONCLUSION 
Our investigations revealed that 
the T 3 form of thyrotoxicosis had 
some characteristic features in course, 
diagnosis and treatment. 
The disease affected the young 
age and had a tendency towards 
relapses. The cardiac symptoms were 
leading, especially tachycardia, 
arrhythmias were rare. 
In Тз thyrotoxicosis with large 
diffuse goiter the surgery was 
preferred after reaching an euthyroid 
state. 
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Резюме: Проучени са 25 болни с Тз-форма на тиреотоксикоза. Диагнозата е 
установена въз основа на клинично наблюдение, биохимични показатели, тотални 
Тз и Т4 и ултразвуково изследване на щитовидната жлеза. Проведено е консер­
вативно, а при показания - и оперативно лечение. Установено е, че при тази форма 
на тиреотоксикоза преобладаването на женския пол е по-слабо изразено, средната 
възраст на болните е по-млада, а продължителността на заболяването от началото 
до откриването му е по-голяма в сравнение с обичайната форма. Отбелязва се по-
голям размер на струмата, която е по-плътна и в много случаи налобена. В 
клиничната картина на преден план са сърдечно-съдовите и невро-вегетативните 
симптоми. Само у двама болни има леки прояви на инфилтративна офталмопатия. 
Заболяването показва склонност към рецидивиране. Четирима от болните са опери­
рани поради трудно компенсиране на хипертиреоидното състояние. 
